Quality of Life and Uremic Toxins in HDx
Key facts
- Who runs it
- Mackay Memorial Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 23 people enrolled
- Started
- 1 Mar 2024
- Ended
- 30 Jul 2024
- Type of study
- Interventional
- Treatments tested
- Medium Cut-Off Dialyzer for Expanded Hemodialysis
- Record updated
- 13 November 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adults aged 18 years or older
- Patients receiving maintenance hemodialysis three times weekly for at least 10 years
- Ability to provide written informed consent
Who cannot take part
- Active malignancy
- Other major organ failure
- History of major surgery within the preceding 3 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Expanded hemodialysis (HDx) is a dialysis treatment designed to improve the removal of certain waste products from the blood. However, its effects on health-related quality of life and blood levels of uremic toxins in patients receiving long-term hemodialysis remain uncertain.
Read full original descriptionShow less
This study aimed to evaluate changes in quality of life and uremic toxin levels after switching from conventional hemodialysis to HDx. Patients who had been receiving maintenance hemodialysis for at least 10 years underwent HDx for three months. Quality of life and blood levels of selected uremic toxins were assessed before and after the treatment period.
The study aimed to determine whether switching to HDx was associated with changes in patients' quality of life and uremic toxin profiles.
The group in the trial
- Expanded Hemodialysis (HDx)Treatment being tested
Participants receiving long-term maintenance hemodialysis were switched from conventional hemodialysis to expanded hemodialysis (HDx) using a medium cut-off dialyzer for three months. Hemodialysis was performed three times weekly. Health-related quality of life and uremic toxin levels were assessed at baseline and after the three-month HDx intervention.
Treatment: Medium Cut-Off Dialyzer for Expanded Hemodialysis
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Changes in Quality of Life and Uremic Toxin Profiles After Switching to Expanded Hemodialysis
- Record updated
- 13 November 2026